What is Arvinas Inc (ARVN) stock price today?

Arvinas Inc (ARVN) currently trades at $9.90 per share. The stock has a market capitalization of $633.21M and a P/E ratio of —x.

Is ARVN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Arvinas Inc has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Arvinas Inc's revenue and earnings?

Arvinas Inc has trailing twelve-month (TTM) revenue of $262.60M with profit margins of -30.80%. Earnings per share (EPS) is $-1.14.

ARVN

Arvinas Inc

NASDAQ: ARVN · HEALTHCARE · BIOTECHNOLOGY

$9.90

+0.81% today

Updated 2026-04-30

Market cap

$633.21M

P/E ratio

—

P/S ratio

2.41x

EPS (TTM)

$-1.14

Dividend yield

—

52W range

$6 – $15

Volume

0.9M

Market cap

$633.21M

P/E ratio

—

P/S ratio

2.41x

EPS (TTM)

$-1.14

Dividend yield

—

52W range

$6 – $15

Volume

0.9M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

5.0

Quality

C+

2.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$14.88

+50.30%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy8 Buy8 Hold1 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at -30.80%

- Negative free cash flow $-30.60M

- Revenue declining -84.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$131.40M	$78.50M	$263.40M	$262.60M	$262.60M
Net income	$-271.90M	$-367.30M	$-198.90M	$-80.80M	$-67.40M
EPS	—	—	—	—	$-1.14
Free cash flow	$-280.30M	$-350.70M	$-261.10M	$-275.70M	$-30.60M
Profit margin	-206.93%	-467.90%	-75.51%	-30.77%	-30.80%

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-18	BERKOWITZ, NOAH	Sale	6,435	$11.10
2026-03-06	MORRISON, BRIGGS	Buy	20,000	$13.40
2026-02-27	HOUSTON, JOHN G	Sale	18,822	$13.24

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ARVN	$633.21M	31	5.3	2.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Arvinas Inc trades at $9.90. Our Smart Value Score of 31/100 indicates the stock is weak. TTM revenue stands at $262.60M. with profit margins at -30.80%.

Frequently asked questions

What is Arvinas Inc's stock price?

Arvinas Inc (ARVN) trades at $9.90.

Is Arvinas Inc overvalued?

Smart Value Score 31/100 (Grade F, Strong Sell).

What is the price target of Arvinas Inc (ARVN)?

The analyst target price is $14.88, representing +50.3% upside from the current price of $9.90.

What is Arvinas Inc's revenue?

TTM revenue is $262.60M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio2.41x

ROE-16.20%

Beta1.98

50D MA$11.57

200D MA$10.43

Shares out0.06B

Float0.06B

Short ratio—

Avg volume0.9M

Performance

1 week-1.92%

1 month-3.58%

3 months-23.62%

YTD-13.83%

1 year—

3 years—

5 years—

Compare

ARVN vs LLY →ARVN vs JNJ →ARVN vs ABBV →Stock screener →